Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (21)

« Back to Publications

Optimising the monitoring and management of raised blood pressure including proteinuria testing during pregnancy: the BUMP research programme including 2 RCTs

McManus RJ. et al, (2026)

Penicillin allergy assessment pathway versus usual clinical care for primary care patients with a penicillin allergy record in the UK (ALABAMA): an open-label, multicentre, randomised controlled trial

Sandoe JAT. et al, (2025), The Lancet Primary Care, 1, 100006 - 100006

Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration

Nguyen BT. et al, (2025), Journal of Infectious Diseases, 231, e1080 - e1090

Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT

Hobbs FDR. et al, (2025), Health Technology Assessment, 29

Pramipexole augmentation for the acute phase of treatment-resistant, unipolar depression: a placebo-controlled, double-blind, randomised trial in the UK

Browning M. et al, (2025), Lancet Psychiatry

Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial

Hobbs FDR. et al, (2024), Nature Medicine, 30, 3634 - 3645

Cost-utility analysis of molnupiravir for high-risk, community-based adults with COVID-19: the PANORAMIC trial

Png ME. et al, (2024), British Journal of General Practice, 74, e570 - e579

D-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial

Hayward G. et al, (2024), JAMA Internal Medicine, 184, 619 - 628

Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trial

Creswell C. et al, (2024), The Lancet Psychiatry, 11, 193 - 209

Re: d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial

Hayward G. et al, (2024), JOURNAL OF UROLOGY, 212, 772 - 773

Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial

Kyle SD. et al, (2023), Lancet, 402, 975 - 987

Evidence-based appraisal of two guidelines for the diagnosis of suspected, uncomplicated urinary tract infections in primary care: a diagnostic accuracy validation study

Fanshawe TR. et al, (2023), Journal of Antimicrobial Chemotherapy, 78, 2080 - 2088

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Butler CC. et al, (2023), The Lancet, 401, 281 - 293

Effect of Self-Monitoring of Blood Pressure on Diagnosis of Hypertension During Higher-Risk Pregnancy: The BUMP 1 Randomized Clinical Trial

Tucker KL. et al, (2022), Obstetrical and Gynecological Survey, 77, 637 - 639

Effect of Self-monitoring of Blood Pressure on Diagnosis of Hypertension during Higher-Risk Pregnancy: The BUMP 1 Randomized Clinical Trial

Tucker KL. et al, (2022), JAMA, 327, 1656 - 1665

Load More